VA reduced a Navy veteran's gastroesophageal reflux disease, or GERD, rating from 30% to 10%. In July 2025, the Board of Veterans' Appeals restored the 30% rating and separately awarded 60% from May 13, 2022.

Those were two different findings. VA had not shown the improvement needed to justify the reduction. The evidence for the later period also supported a higher rating under the criteria that applied to this appeal.

I reviewed Board decision A25062915, dated July 24, 2025. What makes it useful is the Board's explanation of the evidence, including why it accepted one private report and gave less weight to another. The decision is more instructive than a simple story about a private opinion beating a VA examination.

The dates that explain the result

DateWhat happened
April 2021VA granted service connection for GERD at 10%, effective March 19, 2021.
December 2021The veteran filed a Supplemental Claim.
January 2022VA increased GERD to 30%, effective November 5, 2021.
May 2022The veteran filed another Supplemental Claim. The record included a private evaluation dated May 13 and a VA examination that month.
August 2022VA proposed reducing GERD to 10%.
December 2022VA issued the reduction decision, effective March 1, 2023.
May and August 2023The veteran requested Higher-Level Review; the resulting decision continued the 10% rating.
July 2024The veteran appealed to the Board on its Direct Review docket.
July 24, 2025The Board restored 30%, awarded 30% for the earlier period before November 5, 2021, and awarded 60% from May 13, 2022.

Restoring 30% and awarding 60% did not create two GERD ratings to add together. The orders addressed the reduction and the appropriate evaluation for different periods. The published decision does not establish the veteran's final combined rating, payment amount or implemented back pay.

VA followed the notice process but did not establish improvement

The Board found that VA complied with the notice procedures for this reduction. Its reversal turned on the evidence of improvement.

The 30% evaluation had been in effect for less than five years. The Board explained that even in that situation, a reduction requires evidence of actual improvement that reflects better functioning under the ordinary conditions of life and work. It applied Brown v. Brown and the relevant rating regulations to the veteran's history.

The record still described reflux, difficulty swallowing, pain, nausea and sleep disturbance. The veteran continued taking medication. A December 2021 examiner had described the GERD as controlled with medication, but the Board considered that description alongside the continuing symptoms and functional effects throughout the record.

It found that the required improvement had not been demonstrated and restored the 30% rating effective March 1, 2023.

That finding is narrower than saying words such as “stable” or “controlled” can never support a reduction. They have to be read in context. The relevant comparison is what changed in the condition and the person's functioning, not whether one examination used a milder adjective.

The Board weighed two private reports differently

The November 2021 private report described substantial symptoms and characterized their overall effect as severe. For the period before May 13, 2022, however, the Board gave greater weight to the April and December 2021 VA examinations when deciding whether a rating above 30% was supported.

Its stated reason matters: those examiners had examined the veteran and considered his statements during the examinations. The Board found no indication that the earlier private clinician had met with or examined him. It therefore did not accept that report's conclusion as sufficient to establish the higher level for that earlier period.

The May 2022 private evaluation described a more extensive symptom picture, including disrupted sleep, swallowing difficulties and effects on nutrition and daily functioning. A VA examination that month also documented worsening symptoms and reported two to four weeks of work lost during the preceding year.

For the period beginning May 13, 2022, the Board found the veteran's account and the private evaluation persuasive evidence of symptom combinations producing severe impairment of health. It awarded 60% from that date under the older GERD rating framework.

The source of a report did not decide its weight by itself. The Board examined its basis, its fit with the other evidence and the period it addressed. This case does not establish that buying a private evaluation is necessary, or that using rating-schedule phrases guarantees a higher rating.

This appeal used the older GERD criteria

Before May 19, 2024, GERD did not have its own diagnostic code. This veteran's condition was evaluated by analogy under Diagnostic Code 7346, the older hiatal-hernia criteria. In that framework, 60% was the highest scheduled evaluation and included certain symptom combinations causing severe impairment of health.

VA's digestive-system rule change took effect May 19, 2024 and introduced Diagnostic Code 7206 for GERD. The Board explained that this appeal's relevant period ended before that change, so it applied the older criteria.

The date of the Board's decision was 2025. That did not make the 2024 criteria applicable to an earlier period. Anyone comparing this case with their own needs to check the period under review and the rating criteria that apply to it.

The medication discussion also depended on the diagnostic code. The Board applied Jones v. Shinseki when explaining why relief from medication could not be used to deny a higher rating under the older code's wording. That is not a reason to stop treatment or change medication to document symptoms.

A proposed reduction has two different response clocks

Under 38 CFR § 3.105(e) and (i), when the proposed reduction would lower compensation payments currently being made:

  • The notice provides 60 days to present additional evidence supporting continuation of the existing payment level.
  • A request for a predetermination hearing must be received by VA within 30 days of the notice to receive the hearing protection described in the regulation. A timely request continues the existing payment level pending the final determination.

Those are separate deadlines. Do not assume that the 60-day evidence window is also the hearing-request window. Read the actual notice and its instructions promptly. The rule has a specific scope, and other protections or procedures may depend on the facts.

A final reduction decision presents a different procedural question from a proposed reduction. VA's decision-review guidance explains the available review routes. An accredited representative can help identify which deadline and route apply to a particular notice.

What I would take from the evidence discussion

Start with the comparison VA is making. Which earlier evidence supported the existing rating? Which later evidence is said to show improvement? Does that later evidence explain a change in daily functioning, or does it describe continuing symptoms in different words?

Then separate the issues. Evidence that a reduction was improper and evidence that a higher rating is warranted can overlap, but they answer different questions. In this case, the Board addressed both and reached different conclusions for different time periods.

For GERD, the decision shows why a useful record may discuss meals, swallowing, sleep, treatment and work effects alongside the symptoms recorded during an appointment. Those details should describe what actually happens, including variation over time. A clinician's reasoning matters more than a request to reproduce a phrase from the rating schedule.

The veteran chose Direct Review, which limited the Board to the existing evidentiary record identified in the decision. That choice worked with the evidence available here. It is not proof that Direct Review is the right route for every reduction, particularly when relevant new evidence still needs to be submitted. VA explains the different Board Appeal options.

Source and scope

This article is based on the full official text of A25062915, not the underlying medical file or a summary generated from it. The decision was issued by Acting Veterans Law Judge J. Saikh. I also checked the applicable notice regulation against the eCFR version current through September 14, 2026 and the 2024 digestive-system final rule.

Board decisions resolve individual appeals and are not binding precedent for other veterans. This one does not establish a reduction-reversal rate, a preferred type of clinician, a guaranteed review timeline or a payment amount. It shows how the Board evaluated this record.

I'm Landon, founder of Claim Raven and an Army veteran. Claim Raven sells claim-preparation tools. This case analysis is educational and is not a substitute for advice about your own decision and deadlines.

Where to go next